From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.07
First Reported 2008
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.36
Pain Relevance 0.14

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (MSC) DNA binding (MSC)
MSC (Homo sapiens)
Pain Link Frequency Relevance Heat
chemokine 4 97.08 Very High Very High Very High
cytokine 12 88.00 High High
Inflammation 10 49.68 Quite Low
Etanercept 2 32.28 Quite Low
Adalimumab 2 28.60 Quite Low
Infliximab 2 28.00 Quite Low
antagonist 9 5.00 Very Low Very Low Very Low
ischemia 8 5.00 Very Low Very Low Very Low
substance P 7 5.00 Very Low Very Low Very Low
Pain 7 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Injury 5 94.32 High High
Myocardial Infarction 13 66.24 Quite High
Adhesions 1 61.44 Quite High
Metastasis 1 56.68 Quite High
INFLAMMATION 12 49.68 Quite Low
Disease 13 47.84 Quite Low
Graft Vs Host Disease 5 46.16 Quite Low
Communicable Diseases 1 41.88 Quite Low
Autoimmune Disease 3 25.44 Quite Low
Cv Unclassified Under Development 8 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In our experience, this substitute for FCS is effective for MSC and ADSC expansion in vitro: it reduces the cell doubling time by at least 30% and the cells retain their morphology and functions.
Regulation (effective) of Gene_expression (expansion) of MSC
1) Confidence 0.07 Published 2010 Journal Stem Cells International Section Body Doc Link PMC2968415 Disease Relevance 0.06 Pain Relevance 0.04
in the success of MSC therapies is positive, since SDF-1?
Regulation (success) of Gene_expression (therapies) of MSC
2) Confidence 0.04 Published 2008 Journal Biologics : Targets & Therapy Section Body Doc Link PMC2727904 Disease Relevance 0.30 Pain Relevance 0.09

General Comments

This test has worked.

Personal tools